Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Long-Term-Assets" stands at 29.63 Billion Japanese Yens as of 09/30/2025.
As of the end of Astellas Pharma Inc.'s second quarter, the item "Other Long Term Assets" stands at 29.63 Billion JPY. This represents a decrease of -88.74 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.08 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 3.08 Billion Japanese Yens.
The 3 year change is -40.83 Billion Japanese Yens.
The 5 year change is -22.30 Billion Japanese Yens.
The 10 year change is -35.98 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |